Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06935435 · ClinicalTrials.gov registry record · NA
Effects of Distinct Nebraska-Dry Bean Market Classes on Gut Microbiota
A NA study of Gut -Microbiota and Dietary Intervention, sponsored by University of Nebraska Lincoln.
- Active
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06935435: Active NA study of Gut -Microbiota and Dietary Intervention, sponsored by University of Nebraska Lincoln.
NCT06935435 is a NA study of Gut -Microbiota and Dietary Intervention that is active but no longer recruiting, run by University of Nebraska Lincoln. The registered enrollment target is 12 participants, below the 48-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06935435, a NA study of Gut -Microbiota and Dietary Intervention, is active but no longer recruiting, sponsored by University of Nebraska Lincoln.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Beans are well known for their health benefits. Many of these benefits relate to gut health, as many of the nutrients found in beans support beneficial microbes that live in the gut. However, beans have a lot of genetic diversity. This diversity has led to different bean market classes with different colors, sizes, and nutrient profiles. Differences between bean market classes may trigger different effects on gut microbes and health, but this is poorly understood. The goal of the pilot clinical trial is to make comparisons (1) between two different bean market classes (pink beans, great northern beans) and (2) between a bean mixture (pinto, kidney, black, pink, and great northern beans) and individual bean market classes. The study will assess whether bean market classes differ in their effects on gut microbes, blood pressure, metabolism, and gut symptoms in adults with and without obesity.
Primary Outcome
Dose-dependent changes in bacterial composition, and precisely the relative abundance of Faecalibacterium, in fecal samples, as assessed by 16S rRNA gene amplicon sequencing.
Conditions Studied
Interventions
- OTHER Pink Beans
- OTHER Great Northern Beans
- OTHER Five-Bean Mixture
Study Locations (1)
Nebraska
- Nebraska Food for Health Center - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What the registry record for NCT06935435 still lists
NCT06935435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 48-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Gut -Microbiota appearing as the primary indexed condition, and to 3 interventions - of which Pink Beans is the first listed.
NCT06935435 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT06935435 about?
NCT06935435 is a clinical study titled "Effects of Distinct Nebraska-Dry Bean Market Classes on Gut Microbiota". Beans are well known for their health benefits. Many of these benefits relate to gut health, as many of the nutrients found in beans support beneficial microbes that live in the gut. However, beans have a lot of genetic diversity. This diversity has led to different bean market classes with differen...
What is the current status of trial NCT06935435?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-05-08. Estimated completion is 2027-04-30.
What conditions does trial NCT06935435 study?
This clinical trial studies the following conditions: Gut -Microbiota, Dietary Intervention.
What interventions are being tested in trial NCT06935435?
The interventions under investigation include: Pink Beans (OTHER), Great Northern Beans (OTHER), Five-Bean Mixture (OTHER).
Who is sponsoring clinical trial NCT06935435?
This trial is sponsored by University of Nebraska Lincoln, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06935435 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut -Microbiota
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06935435's enrollment target sits among peer trials
12 10th of 9 the lowest of 9 other Gut -Microbiota trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gut -Microbiota trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Walnuts as an Infant Solid Food for Health
RECRUITING · NA
-
Dietary Wild Blueberries and Joint Health
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
Peanuts for Cardiometabolic, Brain, and Intestinal Health
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
RECRUITING · NA
-
Gut Mini-Pill Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI